We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Li Wen

Li Wen MD, PhD

Senior Research Scientist, Director of Core Laboratory of Yale Center for Clinical Investigation, Yale University School of Medicine, New Haven, CT

Senior Research Scientist, Section of Endocrinology, Yale School of Medicine, New Haven Connecticut; Director of the Core Laboratory of Yale Center for Clinical Investigation; Group Leader of Diabetes Research Group; Executive member of Yale Diabetes Research Center. 

Li Wen graduated in medicine from Capital University of Medicine in Beijing, China, and later specialized in clinical immunology and infectious diseases in the same university. She has a PhD from King’s College, University of London.  After postdoctoral training at the Departments of Immunobiology and Internal Medicine (Endocrinology), she became a faculty member in the Section of Endocrinology, Department of Internal Medicine at Yale University School of Medicine.  She has authored and co-authored over 90 peer reviewed publications in Immunology and Diabetes, including papers in Nature, Nature Medicine, the Lancet, Journal of Clinical Investigation, Journal of Experimental Medicine, Diabetes and more.  She was a pioneer in the study of the role of gut microbiota in type 1 diabetes, with a seminal publication in Nature on this subject.  Dr. Wen’s current research activities focus on the role of gut microbiota in disease and health, the role of antibiotics in fetal immune programming and immune tolerance and the role of innate immunity in diabetes. She is currently a member of the editorial board of the journal Diabetes.

Disclosures

Dr. Wen reports no disclosures.